No one’s in favor of fraud, and that goes double when it impacts a federal program that’s expected to spend $588 billion by 2025. Lawmakers took a critical look at Medicaid fraud oversight at a recent hearing and said the program’s fraud, waste, and abuse is a growing problem.
Medicaid paid out $37 billion in fiscal year 2017, an increase of 157 percent since 2013, Sen. Ron Johnson (R-Wisc.), said at the Senate Homeland Security and Governmental Affairs hearing. Johnson, who chairs the committee, said he was worried that Medicaid is growing at an unsustainable rate and lacks the controls to detect and mitigate fraud, waste, and abuse.
Johnson’s condemnation of Medicaid anti-fraud efforts was echoed by Ranking Member Claire McCaskill (D-Mo.), who said the level of Medicaid improper payments was “outrageous”.
The hearing followed on the heels of a report from Republican committee members that include a number of recommendations designed to improve Medicaid’s approach to fraud, waste, and abuse. For example, the report said Medicaid should immediately implement 11 recommendations made by the Government Accountability Office, such as reviewing Medicaid eligibility determinations and improving anti-fraud education.
Some of the report’s findings were addressed by a new Medicaid anti-fraud strategy that was rolled out the day before the hearing. The strategy calls for new audits to assess how the states are determining who’s eligible for Medicaid benefits, as well as some targeted audits of Medicaid managed care organizations.
The Centers for Medicare & Medicaid Services Adminstrator Seema Verma was asked to testify at the Senate hearing but declined due to scheduling issues. Johnson said he recently spoke with Verma and said she was open to testifying at future hearings.
Read my story here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)